NASDAQ:NOVN

Delisted

Novan, Inc. Stock News

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$0.0941

+0 (+0%)

At Close: Nov 20, 2023

Novartis expands Zolgensma manufacturing capacity with approval of multi-product North Carolina facility

05:15am, Tuesday, 05'th Apr 2022 GlobeNewswire Inc.

Basel, April 5, 2022 – Novartis today announced the U.S. Food and Drug Administration (FDA) has granted commercial licensure approval for its Durham, N.C. site, a multi-product gene therapy manufact

Is WisdomTree International High Dividend ETF (DTH) a Strong ETF Right Now?

10:20am, Monday, 04'th Apr 2022 Zacks Investment Research

Smart Beta ETF report for DTH

Novartis gibt neue Organisationsstruktur bekannt für schnelleres Wachstum, eine stärkere Pipeline und höhrere Produktivität

05:00am, Monday, 04'th Apr 2022 GlobeNewswire Inc.

Ad-hoc-Mitteilung gemäss Art. 53 KR

Novartis announces new organizational structure to accelerate growth, strengthen pipeline and increase productivity

05:00am, Monday, 04'th Apr 2022 GlobeNewswire Inc.

Ad hoc announcement pursuant to Art. 53 LR

Novartis receives positive CHMP opinion for Jakavi® to treat acute and chronic graft-versus-host disease

12:09pm, Friday, 25'th Mar 2022 GlobeNewswire Inc.

Basel, March 25, 2022 — Novartis announced today the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending appr

Novartis receives positive CHMP opinion for Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma in Europe

12:03pm, Friday, 25'th Mar 2022 GlobeNewswire Inc.

Basel, March 25, 2022 — Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the Eur

Novartis PluvictoTM approved by FDA as first targeted radioligand therapy for treatment of progressive, PSMA positive metastatic castration-resistant prostate cancer

08:19pm, Wednesday, 23'rd Mar 2022 GlobeNewswire Inc.

Ad hoc announcement pursuant to Art. 53 LR

4 Penny Stocks Insiders Are Buying

12:54pm, Wednesday, 23'rd Mar 2022 Benzinga

The Dow Jones surged by more than 250 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern a

Sandoz targets growth opportunities in respiratory and complex generics through acquisition of respiratory device company Coalesce

06:15am, Monday, 14'th Mar 2022 GlobeNewswire Inc.

Basel, March 14, 2022 — Sandoz, a Novartis division, announced today that it has successfully acquired the UK-based medical and drug delivery device development company, Coalesce Product Development

Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protection

11:00pm, Sunday, 13'th Mar 2022 GlobeNewswire Inc.

Basel, March 13, 2022 — Novartis today announced new data that reinforce the transformational benefit of Zolgensma® (onasemnogene abeparvovec), an essential one-time treatment for spinal muscular

Novan Acquires EPI Health To Bolster Commercial Force For Potential Marketing Of Its lead Products

04:10pm, Friday, 11'th Mar 2022 Benzinga

Novan Inc (NASDAQ: NOVN ) has acquired EPI Health LLC , a specialty pharmaceutical company focused on the U.S. dermatology market. EPI Health offers a product portfolio that includes four prescription products across psoriasis, rosacea, dermatosis, and acne, with a 2021 operating revenue of $17.6 million. Deal consideration of $27.5 million consists of $11.0 million in cash and $16.5 million in … Full story available on Benzinga.com

Novan acquires EPI Health for upfront payment of $27.5M and milestone payment of $23.5M

11:42am, Friday, 11'th Mar 2022 Seeking Alpha

Novan (NOVN) is acquiring EPI Health, LLC, a specialty pharmaceutical company focused on the U.S

Novan Acquires EPI Health, a Specialty Dermatology Company

11:35am, Friday, 11'th Mar 2022 GlobeNewswire Inc.

Acquisition Represents Forward Integration as a Commercial Organization Acquisition Represents Forward Integration as a Commercial Organization

Aktionärinnen und Aktionäre von Novartis heissen an der ordentlichen Generalversammlung alle Anträge des Verwaltungsrats gut

02:19pm, Friday, 04'th Mar 2022 GlobeNewswire Inc.

Basel, 4. März 2022 – Die Aktionärinnen und Aktionäre von Novartis stimmten heute an der ordentlichen Generalversammlung (GV) des Unternehmens allen Vorschlägen des Verwaltungsrats zu. In Übere

Les actionnaires de Novartis approuvent toutes les résolutions proposées par le Conseil d’administration lors de l’Assemblée générale ordinaire